Akebia Therapeutics Inc. (AKBA) slipped -6.33% or -0.41 to $6.07. It is approximately 1.07 million shares traded, which is 87.61% compare to the average total volume 1.22 million. The market cap of AKBA is $714.71 million. The year to date change is 5.4%. The 52 week price range is from $5.2 to $11.6. Price of AKBA have changed 7.28% during last week. It have changed -14.74% over last month, 5.37% over last 3 months, -13.48% over last 6 months and -33.54% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 7.37. It is 21.42% above current price. The 200-day Moving Averages for AKBA is 7.67. It is 26.36% above current price. The 52-week High is 11.6. It is 91.10% from the current price. The 52-week Low is 5.2. It is -14.33% from current price.
There are some statistics of AKBA. It is has market cap $714.71 million. The share outstanding is 117.74 million. The average volume is 1.22 million. The percent of top 15 Institution holding is 85.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -37.86%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -21.10%.